ProLectin-M Demonstrates Significant Activity Against Influenza and Respiratory Syncytial Virus
28 févr. 2023 08h00 HE
|
BIOXYTRAN, INC.
Activity in Influenza and Respiratory Syncytial Virus highlights the broad- spectrum antiviral potential of ProLectin-M BOSTON, MASSACHUSETTS, Feb. 28, 2023 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC....
Simple HealthKit Raises $8M to Transform Health Diagnostics and Follow-Up Care; Expands Portfolio to Include Solutions for Sexual Health, Tripledemic
06 févr. 2023 10h00 HE
|
Simple HealthKit
FREMONT, Calif., Feb. 06, 2023 (GLOBE NEWSWIRE) -- Simple HealthKit, addressing health inequity with the first human-centric, end-to-end healthcare platform that builds and delivers diagnostics,...